Lykos Therapeutics may have shed three-quarters of its staff in the wake of the FDA's rejection of its MDMA candidate for ...

In a short statement Friday, Lykos Therapeutics expressed optimism about a recent meeting with the regulator to discuss next ...

Lykos Therapeutics, whose lead asset, midomafetamine capsules (MDMA), failed to win the FDA nod in August, said that the ...

Lykos Therapeutics said it had a “productive” meeting with the FDA to discuss a path forward for its recently rejected PTSD ...

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down. Emerson has ...

After the turbulent reaction to Lykos Therapeutics’ failure to get its MDMA formulation approved, clinicians and industry ...

Why Harris-Walz? The women say they believe Donald Trump, the Republican candidate, would reduce funding for Medicaid and Medicare spending and repeal the Affordable Care Act. They say that would ...

Lykos Therapeutics is slashing around 75% of its staff following the FDA's decision not to approve its MDMA-assisted therapy for post-traumatic stress disorder (PTSD) last week, with founder Rick ...

Recommended Reading In tone-setting verdict, FDA rejects MDMA as a therapy aid for PTSD The CEO of Lykos Therapeutics will step down after the company’s efforts to win a milestone approval for ...

(Reuters) - Lykos Therapeutics said on Thursday longtime CEO Amy Emerson would step down from the role, in the latest shakeup after the U.S. health regulator declined to approve its MDMA-based ...

Drill rigs will be deployed at Lykos’ Bosnia-Herzegovina projects after results confirm potential for significant ...

Kid Lykos will compete in the 2024 British J Cup. Earlier this week, RevPro began to announce participants for the 2024 British J Cup with Robbie X, Lio Rush and more being announced for the ...